Biote (BTMD) Net Income towards Common Stockholders (2021 - 2026)

Biote's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders fell 83.4% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $16.3 million (down 22.67% YoY), while the FY2025 annual figure was $31.6 million, up 900.86% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $2.3 million, down from $2.6 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $13.7 million in Q1 2025, with the low at -$21.3 million in Q2 2022.
• The 5-year median for Net Income towards Common Stockholders is $3.2 million (2025), against an average of $2.5 million.
• The sharpest annual moves came in 2022 and 2023: Net Income towards Common Stockholders tumbled 318.51% in 2022, then surged 50100.0% in 2023.
• Biote's Net Income towards Common Stockholders stood at $12.8 million in 2022, then slipped by 2.61% to $12.5 million in 2023, then slumped by 70.32% to $3.7 million in 2024, then dropped by 29.33% to $2.6 million in 2025, then slipped by 12.99% to $2.3 million in 2026.
• Business Quant data shows BTMD's Net Income towards Common Stockholders at $2.3 million in Q1 2026, $2.6 million in Q4 2025, and $8.2 million in Q3 2025.